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Objective: Magnetic resonance imaging was used to evaluate left ventricular reverse
remodeling at long-term follow-up (3–4 years) after restrictive mitral annuloplasty in
patients with early stages of nonischemic, dilated cardiomyopathy, and severe mitral
regurgitation.
Methods: Twenty-two selected patients (eligible to undergo magnetic resonance im-
aging) with mild to moderate heart failure (mean New York Heart Association class
2.26 0.4), dilated cardiomyopathy (left ventricular ejection fraction 37%6 5%, left
ventricular end-diastolic volume 215 6 34 mL), and severe mitral regurgitation
(grade 3–41) underwent restrictive mitral annuloplasty. Magnetic resonance imaging
was performed 1 week before surgery and repeated after 3 to 4 years.
Results: There was no hospital mortality or major morbidity. Two patients died during
follow-up (9%), and 2 patients could not undergo repeat magnetic resonance imaging
because of comorbidity. New York Heart Association class improved from 2.26 0.4
to 1.2 6 0.4 (P , .05). Mitral regurgitation was minimal at late echocardiographic
follow-up. There were significant decreases in indexed (to body surface area) left
atrial end-systolic volume (from 84 6 20 mL/m2 to 68 6 12 mL/m2, P , .01), left
ventricular end-systolic volume (from 42 6 14 mL/m2 to 31 6 12 mL/m2, P ,
.01), left ventricular end-diastolic volume (from 110 6 18 mL/m2 to 80 6 17 mL/
m2, P , .01), and left ventricular mass (from 76 6 21 g/m2 to 66 6 12 g/m2, P 5
.03). Forward left ventricular ejection fraction improved from 37% 6 5% to 55%
6 10% (P, .01). Indexed left atrial end-diastolic volume did not show a significant
decrease (from 48 6 16 mL/m2 to 44 6 10 mL/m2, P 5 .15).
Conclusion: Magnetic resonance imaging confirms sustained significant reverse left
atrial and ventricular remodeling at late (3–4 years) follow-up in patients with noni-
schemic, dilated cardiomyopathy, and mild to moderate heart failure after restrictive
mitral annuloplasty.
M
agnetic resonance imaging (MRI) is currently considered the gold standard
for the assessment of left ventricular (LV) function and volumes.1 Advan-
tages of MRI over echocardiography are the superior image quality and the
3-dimensional quantification possibilities with high reproducibility, implying that
smaller sample sizes are needed to prove statistical significance of changes in LV vol-
umes after therapy.2 MRI may therefore be the most appropriate imaging technique for
the evaluation of surgical treatments for heart failure. In a previous study, we presented
MRI data on short-term follow-up after restrictive annuloplasty in patients with noni-
schemic, dilated cardiomyopathy, and severe mitral regurgitation (MR).3 Significant
left atrial (LA) and LV reverse remodeling were noted 2 months after surgery. Moreover,
LV ejection fraction (LVEF) improved significantly. However, whether these beneficial
effects are sustained at long-term follow-up is not clear.4 In the current study, the persis-
tence of reverse remodeling at long-term follow-up after restrictive mitral annuloplasty is
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‘‘i’’ 5 indexation to body surface area
LA 5 left atrial
LAEDV 5 left atrial end-diastolic volume
LAESV 5 left atrial end-systolic volume
LV 5 left ventricular
LVEDV 5 left ventricular end-diastolic volume
LVEF 5 left ventricular ejection fraction
LVESV 5 left ventricular end-systolic volume
MR 5 mitral regurgitation
MRI 5 magnetic resonance imaging
NYHA 5 New York Heart Association
evaluated with MRI. Twenty-two selected patients with
nonischemic, dilated cardiomyopathy, mild to moderate heart
failure, and severe MR were evaluated by MRI within 1 week
before restrictive mitral annuloplasty, and repeat imaging
with MRI was performed at 3 to 4 years after surgery.
Materials and Methods
Patients
Twenty-two selected patients (18 male, 4 female, mean age 576 15
years) with mild to moderate heart failure and dilated cardiomyop-
athy (New York Heart Association [NYHA] class 2.2 6 0.4, LV
end-diastolic dimension 61 6 5 mm, forward LVEF 37% 6 5%,
LV end-diastolic volume [LVEDV] 2156 34 mL) who were sched-
uled for isolated restrictive mitral annuloplasty were included. All
patients presented with nonischemic, dilated cardiomyopathy (coro-
nary artery disease excluded on coronary angiography) and severe
functional MR on echocardiography. The patients had 3 to 41
MR (central jet) secondary to LV and annular dilatation and systolic
restrictive motion of mitral leaflets (Carpentier type IIIb). All
patients were receiving optimized medical therapy and kept on an
optimal regimen during the study period.
Patients selected for this study had to be eligible to undergo
repeat MRI examination. Therefore, in addition to general MRI
exclusion criteria (ie, pacemakers/defibrillators, intracranial clips,
pregnancy, claustrophobia), disease-related specific criteria were
applied. These included the presence of (supra)ventricular arrhyth-
mias or an existing indication for postoperative (biventricular) pace-
maker/defibrillator implantation. To maintain uniformity of surgical
intervention in this small patient group, additional valve surgery, in-
cluding tricuspid valve repair, was another exclusion criterion.
These factors inevitably limited the patient selection to those with
relatively mild heart failure, a group of patients representing the bet-
ter part of our heart failure program. None of the patients had pulmo-
nary hypertension, and all patients had preserved right ventricular
function. MRI was performed within 1 week before surgery and re-
peated 3 to 4 years later (43 6 8 months). At follow-up, a routine
transthoracic echocardiographic examination was performed.
Surgery
All surgical procedures were performed via a midline sternotomy
under normothermic cardiopulmonary bypass with intermittent
antegrade warm blood cardioplegia. The mitral valve was exposed1248 The Journal of Thoracic and Cardiovascular Surgery c Jthrough a vertical transseptal approach along the right border of
the foramen ovale, leaving the roof of the left atrium untouched.
Ring size (Carpentier-Edwards Physio ring, Edwards Lifesciences,
Irving, Calif) was determined after careful measurement of the inter-
commissural distance and height of the anterior leaflet, and then
downsizing by 2 ring sizes (ie, size 26 when measuring 30). All
patients had intraoperative transesophageal echocardiographic
assessment of valve function. Mitral valve repair was considered
successful if there was no residual MR and a leaflet coaptation
height of at least 8 mm at the A2-P2 level was achieved on intrao-
perative echocardiography.
Magnetic Resonance Imaging
MRI was performed using a 1.5 T MRI scanner (ACS-NT15 Gyro-
scan with the Powertrack 6000 gradient system; Philips Medical
Systems, Best, The Netherlands). The body coil was used for trans-
mission, and a 5-element phased-array synergy cardiac-coil was
placed on the chest for signal reception. Standard 2- and 4-chamber
long-axis series and a complete set of short-axis cine acquisitions
were performed (conform standard cardiac MRI protocols5 using
steady-state free precession6) with the patient performing a breath
hold in end expiration. Imaging parameters of the 2- and 4-chamber
long-axis series and for the short-axis series were as follows: TE/TR
5 1.52/3.0, flip angle 5 50 degrees, field of view 5 350 mm, scan
matrix 5 192 3 153, slice thickness 5 8 mm, and gated cardiac
triggering with retrospective reconstruction of 30 phases. For the
short-axis series, 10 to 12 parallel oriented slices were acquired
with a 2-mm slice gap, 1 slice during each breath hold. LVEDV
and LV end-systolic volume (LVESV) (from short-axis MRI7)
and LAEDV and LAESV (from measuring biplane area-length in
orthogonal long-axis 2- and 4-chamber views3) were obtained by
manual segmentation. Image analysis was performed blinded with
respect to echocardiographic data.
In the presence of significant MR, LVEF does not represent the
true forward blood flow (through the aortic valve) because a substan-
tial part of the blood volume leaks back into the left atrium. To cor-
rect for this effect, we have recently used the ‘‘forward LVEF,’’
which was derived by calculating the ratio of the forward stroke vol-
ume and the EDV.3 The forward stroke volume was obtained from
aortic flow measurements derived from velocity-encoded MRI.8
QMass and QFlow software (Medis, Leiden, The Netherlands)
were used for image analysis. MRI examination was repeated at
3 to 4 years follow-up, and similar parameters were assessed. Signif-
icant reverse remodeling was defined as a volume reduction exceed-
ing 15%. An increase in forward LVEF of 5% or more and
a decrease in LV mass 10 g or more were considered significant.3
The medical ethics committee of our institute approved all examina-
tions. All patients gave informed consent.
Statistical Analysis
Continuous data were expressed as mean 6 standard deviation and
compared using the Student t test for paired data.
Results
Clinical Outcome
All patients underwent successful mitral valve repair. The
median annuloplasty ring size was 26. Intraoperative transe-
sophageal echocardiography showed a mean coaptationune 2008
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absent in the remaining patients. None of the patients had mi-
tral stenosis, and systolic anterior movement of the anterior
leaflet was not observed on echocardiography. There was
no in-hospital or 30-day mortality, and no major complica-
tions occurred.
During follow-up, 2 patients (9%) died of refractory heart
failure before repeat MRI. In 2 additional patients, follow-up
MRI could not be performed because of comorbidity (Alz-
heimer’s disease and amyotrophic lateral sclerosis). There
were no cases of endocarditis or thromboembolic events.
At late follow-up (436 8 months) NYHA class was 1.26
0.4 (P , .05 vs baseline), and transthoracic echocardio-
graphy showed minimal MR (mean grade 0.6 6 0.5), with
a mean leaflet coaptation length of 86 3 mm, without mitral
stenosis.Reverse Remodeling onMagnetic Resonance Imaging
Figure 1 shows the LA and LV reverse remodeling assessed
by MRI. The MRI results are summarized in Table 1.
Although LAEDVi (‘i’ indicating indexation to body surface
area) did not decrease significantly (predefined by a volume
reduction$ 15%) (from 486 16 mL/m2 to 446 10 mL/m2,
P 5 .15), significant LA reverse remodeling for EDV
occurred in 56% of the patients. Individual data are presented
in Figure 2, A. LAESVi decreased significantly from 846 20
mL/m2 to 68 6 12 mL/m2 (P , .01), with significant LA
reverse remodeling for ESV occurring in 67% of patients
(Figure 2, B).
LVEDVi decreased significantly from 1106 18 mL/m
2 to
806 17 mL/m2 (P, .01). Significant reverse remodeling of
LVEDV occurred in the majority of patients (89%); individ-
ual data are shown in Figure 3, A. LVESVi significantlyFigure 1. Patient example illustrating reverse remodeling of the left atrium and left ventricle 43 months after mitral
valve repair. Four-chamber views during end diastole (A) and end systole (B) before surgery show severe dilatation
of the left atrium (LAEDV 128 mL, LAESV 216 mL) and left ventricle (LVEDV 311 mL, LVESV 90 mL) caused by volume
overload secondary to severe MR. The 4-chamber views during end diastole (C) and end systole (D), 43 months after
surgery, show a reduction in LA volumes (LAEDV 88 mL, LAESV 145 mL) and LV volumes (LVEDV 210 mL, LVESV 89 mL).
A restrictive semirigid ring is implanted in the mitral annulus, resulting in signal loss because of paramagnetic
material inside the ring.
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with 72% of patients showing significant reverse remodeling
of LVESV (Figure 3, B). Overall, 2 patients (11%) did not
show any (LA or LV) reverse remodeling.
Forward LVEF increased significantly over time: from
37% 6 5% at baseline to 55% 6 10% (P , .01). Of note,
94% of patients showed a significant increase in forward
LVEF (predefined as an increase of $ 5% in forward
LVEF); individual results are shown in Figure 4, A. Indexed
LV mass showed a statistically significant decrease (prede-
fined by a mass reduction $ 10 g) from 76 6 21 g/m2 to
66 6 12 g/m2 (P 5 .03). In addition, 83% of the patients
showed a significant decrease in LV mass (Figure 4, B).
Discussion
This study demonstrates the ability of MRI to report in
a detailed fashion on various aspects of the LV reverse
remodeling process (forward LVEF, LV and LA volumes).
All previous studies on improvement in LVEF and LV reverse
remodeling after restrictive mitral repair in patients with di-
lated cardiomyopathy used echocardiography, which is lim-
ited by substantial intra- and interobserver variations and
geometric assumptions needed for quantification of LVEF
and LV volumes. The same measurements done with MRI
have been reported to be highly accurate and reproducible.3,7
MRI has a superior image quality compared with echocardi-
ography and is not hampered by technical limitations, such
as suboptimal acoustic windows. Moreover, MRI has the ad-
vantage of acquiring every arbitrary double obliquely ori-
ented imaging plane in 3 dimensions. Accordingly, MRI is
considered the gold standard for assessment of LA and LV
volumes, and its noninvasive nature and high reproducibility
make this technique ideal for follow-up studies after therapy.9
The high reproducibility allows for smaller study sample sizes
to prove statistical significance. For example, to demonstrate
a 10-mL difference in LVEDV with aP value less than .05 and
a power of 90%, evaluation of only 12 patients is needed when
MRI is used, compared with 121 patients when echocardiog-
raphy is used.2 Indeed, in the current study, significant LA and
LV reverse remodeling were statistically significantly proven
with only 18 patients. Moreover, MRI permits easy correction
for the influence of MR on LVEF by the use of the forward
stroke volume (reflecting true forward blood flow through
the aortic valve), as applied in the current study. This ap-
proach also permits a better appreciation of the true effect of
mitral valve surgery on forward blood flow, reflected in the
current study by a significant increase in forward LVEF.
However, the use of MRI for follow-up purposes is still
limited by technical factors, and, as explained before, the pa-
tient group presented here represents the better part of our
heart failure program. Currently, all patients with heart fail-
ure undergo MRI before surgery, but only those not requiring
implantation of an epicardial LV lead or a pacemaker/defi-
brillator and those without (supra)ventricular arrhythmias
are eligible to undergo follow-up MRI. These
TABLE 1. Magnetic resonance imaging results: Presurgery
and at 43 6 8 months follow-up
Presurgery 43 6 8 mo follow-up P value
LAESV (mL) 165 6 43 132 6 20 ,.01
LAESVi (mL/m
2) 84 6 20 68 6 12 ,.01
LAEDV (mL) 95 6 32 85 6 19 .14
LAEDVi (mL/m
2) 48 6 16 44 6 10 .15
LVESV (mL) 82 6 25 60 6 22 ,.01
LVESVi (mL/m
2) 42 6 14 31 6 12 ,.01
LVEDV (mL) 215 6 34 157 6 32 ,.01
LVEDVi (mL/m
2) 110 6 18 80 6 17 ,.01
Forward LVEF (%) 37 6 5 55 6 10 ,.01
LV mass/BSA (g/m2) 76 6 21 66 6 12 .03
LAESV, Left atrial end-systolic volume; LAEDV, left atrial end-diastolic vol-
ume; LVESV, left ventricular end-systolic volume; LVEDV, left ventricular
end-diastolic volume; LVEF, left ventricular ejection fraction; LV, left ventric-
ular; BSA, body surface area; i, indexation to body surface area.
Figure 2. Individual data of patients demonstrating the changes over time in LAEDVi (A) and LAESVi (B). Examination
1 concerns MRI before surgery; examination 2 concerns MRI at 436 8 months follow-up. Mean values (circular data
points and solid line); individual data (triangles and dotted lines).1250 The Journal of Thoracic and Cardiovascular Surgery c June 2008
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solid line); individual data (triangles and dotted lines).contraindications currently hamper widespread use of MRI in
patients with heart failure. It is expected that these technical
limitations of MRI will be overcome in the near future, which
will greatly increase the possibilities of follow-up imaging in
patients with heart failure.
In the current study, the beneficial effects of restrictive mi-
tral annuloplasty in a selected group of patients with mild to
moderate heart failure was shown. Currently, not much infor-
mation on the effects of restrictive mitral annuloplasty in this
patient category is available. Acker et al10 recently reported
initial results from the Acorn trial. In this study, a subgroup
of patients with mild heart failure (NYHA class II and rela-
tively preserved LVEF and functional MR) underwent iso-
lated mitral valve surgery, similar to the patients in the
current study. The outcome of this subset of patients was
not reported separately, making direct comparison with the
current findings impossible.Another conclusion that can be drawn from the present
study is that treatment of functional MR in nonischemic
dilated cardiomyopathy by restrictive annuloplasty alone
eliminates MR and leads to LA and LV reverse remodeling
in the majority of this selected patient population. It has
been questioned whether LV reverse remodeling is main-
tained over longer follow-up periods. Our current results
confirm that LV reverse remodeling is indeed present at
long-term follow-up. These favorable results may be related
to the fact that only patients with milder heart failure were in-
cluded (mean NYHA class 2.2 6 0.4 and mean forward
LVEF 37%6 5%), reflecting the less ill patients in our heart
failure program. In addition, only patients with preserved
right ventricular function and without pulmonary hyperten-
sion or significant tricuspid regurgitation were selected. For
reference, in our institution patients with more advanced
stages of heart failure undergo tricuspid annuloplasty when
significant tricuspid regurgitation or severe annular dilatationFigure 4. Individual data of patients demonstrating the changes over time in forward LVEF (A) and LV mass indexed
by body surface area (B). Examination 1 is MRI before surgery; examination 2 is MRI at 43 6 8 months follow-up.
Mean values (circular data points and solid line); individual data (triangles and dotted lines).
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diastolic diameter exceeds 65 mm, an external cardiac
constraint device (CorCap cardiac support device; Acorn
Cardiovascular, St Paul, Minn) is also applied. These patients
have a 6% operative mortality, and long-term results are
currently being evaluated. When LV end-diastolic dimension
exceeds 80 mm, surgical LV restoration is considered as
described by Isomura et al.11
The current results strengthen the hypothesis that grades 3
to 41 functional MR can be successfully treated by restric-
tive mitral annuloplasty in patients with LV dilatation but
relatively mild heart failure (NYHA class II to III). On a pa-
tient basis, 89% and 72% of patients exhibited a significant
reduction in LV volumes. These observations are clinically
relevant because LV function and volumes have been dem-
onstrated to be important predictors of long-term outcome
in patients with LV dysfunction.12,13 Also, LA dimensions
have been shown to provide prognostic information.14,15 In
the present study, LA volume in end systole showed a signif-
icant decrease, although LA volume in end diastole did not
exhibit a decrease in the entire study population.
On the basis of the reverse remodeling observed in the cur-
rent study, one could speculate that the point of no return
(irreversible LV dilatation) was not yet reached in this patient
category, suggesting that mitral valve surgery may be consid-
ered at an earlier stage in patients with nonischemic dilated
cardiomyopathy. Further prospective studies are needed to
confirm the benefit of early surgical intervention in patients
with mild heart failure.
Conclusions
MRI provides a powerful tool for the evaluation of the LV
and LA reverse remodeling process in patients with mild
heart failure with functional MR and nonischemic dilated
cardiomyopathy who underwent isolated restrictive annulo-
plasty. At late (3–4 years) follow-up, sustained significant
LV and LA reverse remodeling was demonstrated using
MRI. It should be emphasized that the current findings
have been obtained in a highly selected patient population
and that further MRI experience in patients with more
advanced stages of heart failure is needed.
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Discussion
Dr Michael Acker (Philadelphia, Pa). I congratulate the authors
for this well-conducted study using what is considered by many
as the gold standard in looking at cardiac volumes. You confirmed
in your patients with moderate heart failure that by correcting MR
we can see reverse remodeling, which we have seen in many other
types of groups. I have 4 questions.
Mitral insufficiency and heart failure are often very dynamic, and
these patients were not that sick. Were these patients really opti-
mized on standard advanced medical therapy before you attempted
to operate? How long were they followed before making the deci-
sion to operate?
Dr Jerry Braun (Leiden, The Netherlands). All patients were on
a good medical treatment strategy. All patients had at least had di-
uretics.
Dr Acker. Were they all on beta-blockers and angiotensin-
converting enzyme inhibitors? If not, what percentage?
Dr Braun. All patients were receiving angiotensin-converting
enzyme inhibitors, and the majority were receiving beta-blockers
(80% or 90%), this was continued after surgery.
DrAcker. I saw that there was a bit of residual MR at your follow-
up (0.66), suggesting that some patients had up to 21MR. If you everne 2008
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of the patients, the ventricle, or the actual mitral valve might indicate
late failure of your repair with a small annuloplasty ring?
Dr Braun. In this group, none of the patients had grade 2 MR.
We know from our studies in ischemic patients, after 4 years about
85% has no grade 2 MR, while 15% has. In that patient group we
tried to relate it to preoperative variables, but were not able to find
a relation. It occurs both in the larger ventricle group as well as in
the smaller ventricle group.
Dr Acker. Nothing about the degree of coaptation depth or
annular size or whether it’s an eccentric jet or central jet would
indicate?
Dr Braun. No, not at all.
Dr Acker. Two of your patients died. At death—I don’t know if
they were censored from your results or not—did they have return of
MR and did you see a lack of reverse remodeling in these 2 patients
who died of progressive heart failure?
Dr Braun. Two patients died. One patient died several months
after surgery, suddenly, probably because of ventricular arrhyth-
mias. The other died shortly after emergent surgery for a vascular
problem. The last echo several months before death showed a com-
petent mitral valve and no progression of LV dilatation.
Dr Acker. You’ve demonstrated that there is reverse modeling
in moderate heart failure. Do you have any evidence that you can
share with us for patients with advanced heart failure secondary to
idiopathic myopathy, such as these, and for patients with ischemic
cardiomyopathy?The Journal of ThorDr Braun. We’re working on our complete series of nonische-
mic patients. Unfortunately, we’re not able to follow them with
MRI, but with echocardiography. We’re still working on that.
I should say that currently we treat these patients with the CorCap
cardiac support device (Acorn Cardiovascular; St. Paul, Minn,
USA) device if they have an LV end-diastolic dimension exceeding
65 mm; we don’t only do a restrictive mitral annuloplasty.
I should say that we treat these patients currently, if they have
a left ventricular end diastolic dimension exceeding 65 mm, not
only by a restrictive mitral annuloplasty, but we also add a CorCap
cardiac support device (Acorn Cardiovascular; St. Paul, Minn,
USA). In the ischemic patients, that we presented at the STS meeting
in San Diego earlier this year we obtained results that are quite
promising, as I said. Maybe I can show a discussion slide.
Dr Starnes. I don’t think we have time.
Dr Braun. The results are very promising.
Dr Hormoz Azar (Norfolk, Va). There will be a certain amount
of remodeling just by inserting the ring. Did you measure the mid-
ventricular diameter and did that show diminution in time, or how
much of it was related just to cinching the ventricle by the ring?
Dr Braun. Of course, that difference is difficult to make. We
measured the volumes in this series, so we get an overall impression
of the ventricle. By echocardiography, we measure the end-diastolic
dimension at the level where the tips of the mitral leaflets close, or at
least where the tips of the papillary muscles are located, and we see
a decrease at that level as well. But that is not a way to discern
whether this is why MR is observed.acic and Cardiovascular Surgery c Volume 135, Number 6 1253
